Literature DB >> 32998591

The Use of Serum Procalcitonin in the Setting of Infected Ureteral Stones: A Prospective Observational Study.

Edward Capoccia1, Patrick Whelan1, Benjamin Sherer1, Pete Tsambarlis1, Wei Phin Tan1, Alexander Chow1, Michael Ryan Farrell1, Brijesh Patel1, Shaan Setia1, Brittany M Wilson2, Yanyu Zhang3, Dimitri Papagiannopoulos1.   

Abstract

Introduction: Infected ureteral stones are a urologic emergency and require urgent decompression. We set out to determine whether serum procalcitonin (PCT) could aid in the diagnosis of infected ureteral stones.
Methods: All consecutive patients presenting to the emergency room from November 9, 2016, to November 10, 2018, with an obstructing ureteral stone were included. All patients had complete blood count, urinalysis (UA), PCT, and urine culture (UCx). Subgroup analysis was performed in a "clinically equivocal" cohort of afebrile patients defined as a leukocytosis >104/μL and UA with <50 white blood cells (WBCs) per high powered field (hpf). Patients with positive and negative UCx were compared.
Results: A total of 231 patients were included, of whom 56 had a positive UCx. Of all covariates, UA WBCs with a cutoff of 9 per hpf performed best at predicting positive UCx with an area under the curve (AUC) of 0.87. PCT did not perform as well with an ideal cutoff of 0.08 ng/mL, having an AUC of 0.77, sensitivity 70.6%, specificity 73.9%, positive predictive value (PPV) 34.3%, and negative predictive value (NPV) 92.9%. When looking at the clinically equivocal cohort, UA WBCs with a cutoff of 6 per hpf appeared to perform best at predicting a positive UCx with an AUC of 0.72. PCT was less predictive in this cohort with an ideal cutoff of 0.3 ng/mL, having an AUC of 0.32, sensitivity 47.1%, specificity 85.2%, PPV 38.1%, and NPV 89.3%.
Conclusion: PCT does not appear to be a superior marker for diagnosing urinary tract infection in the setting of obstructing ureterolithiasis when compared with components of the standard work-up.

Entities:  

Keywords:  infected stones; obstructing urolithiasis; procalcitonin; urinary tract infections

Mesh:

Substances:

Year:  2020        PMID: 32998591      PMCID: PMC9206489          DOI: 10.1089/end.2020.0308

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.619


  18 in total

1.  Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis.

Authors:  Klaus Tschaikowsky; Monika Hedwig-Geissing; Giovanni G Braun; Martin Radespiel-Troeger
Journal:  J Crit Care       Date:  2010-06-19       Impact factor: 3.425

2.  Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: a cross-sectional study.

Authors:  Ying Yu; Xia-Xi Li; Ling-Xiao Jiang; Meng Du; Zhan-Guo Liu; Zhong-Ran Cen; Hua Wang; Zhen-Hui Guo; Ping Chang
Journal:  Infect Dis (Lond)       Date:  2015-09-04

Review 3.  The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever.

Authors:  M Limper; M D de Kruif; A J Duits; D P M Brandjes; E C M van Gorp
Journal:  J Infect       Date:  2010-03-27       Impact factor: 6.072

4.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

5.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

6.  Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever.

Authors:  Catherine Chirouze; Hélène Schuhmacher; Christian Rabaud; Helder Gil; Norbert Khayat; Jean-Marie Estavoyer; Thierry May; Bruno Hoen
Journal:  Clin Infect Dis       Date:  2002-06-17       Impact factor: 9.079

7.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

8.  Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study.

Authors:  Cees van Nieuwkoop; Tobias N Bonten; Jan W van't Wout; Ed J Kuijper; Geert H Groeneveld; Martin J Becker; Ted Koster; G Hanke Wattel-Louis; Nathalie M Delfos; Hans C Ablij; Eliane M S Leyten; Jaap T van Dissel
Journal:  Crit Care       Date:  2010-11-17       Impact factor: 9.097

Review 9.  Update on procalcitonin measurements.

Authors:  Michael Meisner
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

10.  Procalcitonin determined at emergency department as na early indicator of progression to septic shock in patient with sepsis associated with ureteral calculi.

Authors:  Young Hwii Ko; Yoon Seob Ji; Sin-Youl Park; Su Jin Kim; Phil Hyun Song
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.